Beyfortus RSV Antibody Injection
Beyfortus (nirsevimab) is a long-acting monoclonal antibody injection that protects infants against lower respiratory tract disease caused by respiratory syncytial virus (RSV).
HK$4500
ζε
Vaccine Information
Beyfortus (nirsevimab) is a long-acting monoclonal antibody injection that protects infants against lower respiratory tract disease caused by respiratory syncytial virus (RSV). Single 100mg dose.
Preparation
Eligibility
Under 1 year of age and weighing 5kg or more High-risk children aged 1 to under 2 years require 200mg (2 x 100mg)
Service locations
π Wan Chai Clinic Address:
Shop B, G/F, China Hong Kong Tower 8-12 Hennessy Road, Wan Chai, Hong Kong (Near Admiralty MTR station exit F/Tram stop: Arsenal Street)
β
π Mong Kok Clinic Address:
Room 1502-1505, 15/F, T.O.P., 700 Nathan Road, Mong Kok, Kowloon, Hong Kong (Turn left after exiting the elevator. Take another left and continue until you reach the end)
β
Stay ahead in your health journey
Focused on your overall well-being
Health starts with your lifestyle β we assess it fully and build the best prevention plan with you.
Book Now